Diligent Investors LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) during the second quarter, according to its most recent disclosure with the SEC. The firm bought 446 shares of the healthcare conglomerate’s stock, valued at approximately $229,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Advocacy Wealth Management Services LLC raised its holdings in UnitedHealth Group by 75.8% during the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 25 shares during the period. Cascade Investment Advisors Inc. grew its stake in UnitedHealth Group by 100.0% during the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 30 shares in the last quarter. Evolution Advisers Inc. purchased a new stake in UnitedHealth Group in the 1st quarter worth $38,000. Rise Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at about $38,000. Finally, Cordant Inc. purchased a new position in shares of UnitedHealth Group during the first quarter valued at about $45,000. Hedge funds and other institutional investors own 87.25% of the company’s stock.
Analyst Upgrades and Downgrades
UNH has been the subject of a number of research analyst reports. Credit Suisse Group raised their price objective on UnitedHealth Group from $575.00 to $579.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a research note on Thursday, September 8th. Morgan Stanley increased their price target on UnitedHealth Group from $570.00 to $587.00 in a report on Monday, July 18th. Argus boosted their price objective on shares of UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a research report on Monday, July 25th. Finally, UBS Group lifted their price target on shares of UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research note on Thursday, July 21st. Three investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $586.40.
UnitedHealth Group Trading Up 1.1 %
UnitedHealth Group (NYSE:UNH – Get Rating) last released its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. The business had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business’s revenue was up 12.6% on a year-over-year basis. During the same period last year, the company posted $4.70 EPS. Analysts expect that UnitedHealth Group Incorporated will post 21.85 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th were given a dividend of $1.65 per share. This represents a $6.60 annualized dividend and a dividend yield of 1.28%. The ex-dividend date of this dividend was Friday, September 9th. UnitedHealth Group’s payout ratio is presently 34.46%.
In other news, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the sale, the chief accounting officer now owns 34,786 shares of the company’s stock, valued at approximately $18,866,882.82. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of the business’s stock in a transaction on Monday, July 18th. The shares were sold at an average price of $527.90, for a total value of $6,005,390.40. Following the completion of the transaction, the chief executive officer now owns 76,559 shares in the company, valued at $40,415,496.10. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $542.37, for a total transaction of $252,202.05. Following the completion of the transaction, the chief accounting officer now owns 34,786 shares of the company’s stock, valued at approximately $18,866,882.82. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 139,051 shares of company stock valued at $74,450,958. 0.40% of the stock is currently owned by company insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Is The Golden Age Of Homebuilding Already Over?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.